tjpls
Tropical Journal of Pharmaceutical and Life Sciences
Trop. j. pharm. life sci.
Jadoun Science Publishing Group India
IN
https://jadounscience.com
2349-9818
326
Research Article
Evolution of Practical Recommendations for the Management of Diabetes in Patients with COVID-19: An Experimental Observational Study
Kaleem Ahmed Khan
kaleemahmedkhan22@gmail.com
Research Scholar
Rakesh Kumar Jat
rakeshjat75@yahoo.co.in
Research Guide
Department of Pharmacy, Shri J.J.T. University, Jhunjhunu, Rajasthan, India
13
10
2026
Received: 13102026
Copyright (c) 2026
2026
<a rel="license" href="https://creativecommons.org/licenses/by-nc/4.0/"><img alt="Creative Commons License" src="//i.creativecommons.org/l/by-nc/4.0/88x31.png" /></a><p>This work is licensed under a <a rel="license" href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial 4.0 International License</a>.</p>
COVID-19
Diabetes Mellitus
Glycemic Control
Insulin Therapy
Knowledge Assessment
Experimental Management
[
1. Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068-1077.e3. doi:10.1016/j.cmet.2020.04.021
]
[
2. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-550. doi:10.1016/S2213-8587(20)30152-2
]
[
3. Apicella M, Campopiano MC, Mantuano M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782-792. doi:10.1016/S2213-8587(20)30238-2
]
[
4. Ceriello A, Standl E, Catrinoiu D, et al. Issues of diabetes management in people with diabetes and COVID-19 in ICU settings. Diabetes Care. 2020;43(7):1529-1534. doi:10.2337/dc20-1247
]
[
5. Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19. Diabetes Care. 2020;43(7):e77-e78. doi:10.2337/dc20-0723
]
[
6. Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):e3319. doi:10.1002/dmrr.3319
]
[
7. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi:10.1038/s41574-020-00435-4
]
[
8. Drucker DJ. Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):bnaa011. doi:10.1210/endrev/bnaa011
]
[
9. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14(4):513-517. doi:10.1016/j.dsx.2020.04.049
]
[
10. Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in COVID-19. N Engl J Med. 2020;383(8):789-790. doi:10.1056/NEJMc2018688
]
[
11. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-310. doi:10.1016/j.dsx.2020.04.004
]
[
12. Klonoff DC, Umpierrez GE. COVID-19 in patients with diabetes: risk factors that increase morbidity. Metabolism. 2020;108:154224. doi:10.1016/j.metabol.2020.154224
]
[
13. Maddaloni E, Buzzetti R. COVID-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7):e3321. doi:10.1002/dmrr.3321
]
[
14. Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43(6):867-869. doi:10.1007/s40618-020-01236-2
]
[
15. Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? Diabetes Metab Syndr. 2020;14(4):535-545. doi:10.1016/j.dsx.2020.04.044
]
[
16. Gianchandani R, Esfandiari NH, Ang L, et al. Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes. 2020;69(10):2048-2053. doi:10.2337/dbi20-0022
]
[
17. Umpierrez GE, Klonoff DC. Diabetes technology in the inpatient setting during the COVID-19 pandemic. J Diabetes Sci Technol. 2020;14(4):795-797. doi:10.1177/1932296820935175
]
[
18. Rayman G, Lumb A, Kennon B, et al. Guidance on inpatient diabetes care during the COVID-19 pandemic. Diabet Med. 2020;37(7):1087-1089. doi:10.1111/dme.14370
]
[
19. Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes. Diabetologia. 2020;63(8):1500-1515. doi:10.1007/s00125-020-05180-x
]
[
20. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes. Lancet Diabetes Endocrinol. 2020;8(10):823-833. doi:10.1016/S2213-8587(20)30271-0
]
[
21. Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for severe COVID-19. Diabetes Metab. 2020;46(6):438-445. doi:10.1016/j.diabet.2020.07.006
]
[
22. Misra A, Ghosh A, Gupta R. Heterogeneity in presentation of COVID-19 in type 2 diabetes. Diabetes Metab Syndr. 2020;14(4):453-457. doi:10.1016/j.dsx.2020.04.017
]
[
23. Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality. Lancet Diabetes Endocrinol. 2020;8(10):813-822. doi:10.1016/S2213-8587(20)30272-2
]
[
24. Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection. Diabetes Care. 2021;44(1):55-65. doi:10.2337/dc20-2155
]
[
25. Khunti K, Del Prato S, Mathieu C, et al. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44(12):2645-2655. doi:10.2337/dc21-1318
]
[
26. Sathish T, Kapoor N, Cao Y, et al. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review. Diabetes Obes Metab. 2021;23(3):870-874. doi:10.1111/dom.14269
]
[
27. Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis. Diabetes Metab Syndr. 2020;14(6):1563-1569. doi:10.1016/j.dsx.2020.08.015
]
[
28. Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID-19. Diabetes Metab Syndr. 2020;14(5):933-936. doi:10.1016/j.dsx.2020.06.039
]
[
29. Wargny M, Potier L, Gourdy P, et al. Predictors of hospital discharge and mortality in COVID-19 patients with diabetes. Diabetologia. 2021;64(1):1-12. doi:10.1007/s00125-020-05328-8
]
[
30. Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341-342. doi:10.1038/s41574-020-0364-6
]